首页> 美国卫生研究院文献>Infection and Immunity >Induction of cellular and humoral immunological responsiveness to a soluble cercarial antigen preparation from Schistosoma mansoni.
【2h】

Induction of cellular and humoral immunological responsiveness to a soluble cercarial antigen preparation from Schistosoma mansoni.

机译:诱导对曼氏血吸虫的可溶性小肠抗原制剂的细胞和体液免疫应答。

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

The development of immunological responsiveness to a soluble cercarial antigenic preparation (CAP) from Schistosoma mansoni was analyzed in inbred CBA/J mice infected with cercariae, one or multiple times, or sensitized using CAP. Repeated exposure to 75 cercariae at three weekly intervals (3X-75) or subcutaneous administration of 20 mug of CAP (CAP/complete Freund adjuvant [CFA]) stimulated the development of specific anti-CAP lymph node cell blastogenesis. The degree of responsiveness was dependent upon the concentration of CAP in the culture system and was optimal in the dose range of 20 to 30 mug of protein of CAP per culture. Animals exposed once to 75 or 225 cercariae or to two sequential weekly infections with 75 cercariae exhibited a minimal response to CAP in comparison to the responsiveness of 3X-75 or CAP/CFA lymph node cells. Assessment of anti-CAP agglutinating antibody by application of a microtiter passive hemagglutination technique revealed that both 3X-75 and CAP/CFA animals possessed low titers of activity. In addition, both 3X-75 and CAP/CFA sera contained reagin-like antibodies to CAP as detected by the heterologous (rat), 72-h latent period, passive cutaneous anaphylaxis technique.
机译:在感染了尾aria的近交CBA / J小鼠中分析了一次或多次或使用CAP致敏的曼氏血吸虫对可溶性宫颈抗原制剂(CAP)的免疫应答的发展。每三周一次(3X-75)反复接触75尾或皮下注射20杯CAP(CAP /完全弗氏佐剂[CFA])刺激特定的CAP淋巴结细胞胚发生。反应度取决于培养系统中CAP的浓度,并且在每次培养20至30杯CAP蛋白的剂量范围内是最佳的。与3X-75或CAP / CFA淋巴结细胞的反应性相比,一次接触75或225尾c的动物或每周两次连续感染75尾c的动物对CAP的反应最小。通过使用微量滴定被动血凝技术评估抗CAP凝集抗体,发现3X-75和CAP / CFA动物都具有较低的滴度活性。此外,3X-75和CAP / CFA血清均含有通过异源(大鼠),潜伏期为72小时的被动皮肤过敏反应技术检测到的CAP的类植物素样抗体。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号